IRF5-CPP5

IRF5-CPP5 is a cytosolic peptide that selectively inhibits human IRF5 with IC50 values of 15.4 and 15.3 μM for recombinant S430D or wild-type (WT) IRF5 dimerization, respectively.[1].

1601299-92-6

12352209

Toll-like Receptor (TLR)

Immunology/Inflammation

COVID-19-immunoregulation

Inflammation/Immunology

95.38

O=C(NC(C)C(NC(CC(N)=O)C(NC(CC(C)C)C(NCC(NC(CC1=CC=C(C=C1)O)C(NC(CC2=CNC3=CC=CC=C23)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(C)C(NC(CC(C)C)C(NC(CC4=CC=CC=C4)C(NC(C(C)C)C(NC(C(O)C)C(NC(CC5=CC=C(C=C5)O)C(NC(CC6=CNC7=CC=CC=C67)C(NC(C(O)C)C(NC(CC(O)=O)C(NC(CC(C)C)C(NCC(NC(CC(C)C)C(NC(C(C)C)C(NC(CCCCN)C(NC(CCCCN)C(NC(CCCNC(N)=N)C(N8C(CCC8)C(NC(CCCCN)C(N9[C@H](CCC9)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(CCSC)N

C160H245N37O36S

3294.95

[1]Banga J, et al. Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization. Sci Adv. 2020 May 15;6 (20) :eaay1057.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P11072/IRF5-CPP5-SDS-MedChemExpress.pdf

Peptides

No Development Reported